Recipients of solid organs such as the kidney and heart are treated with standard immunosuppressive regimens, and personalized medicine has not yet reached the clinic for this patient population. Biomarkers potentially will allow treatment regimens to be adjusted, according to the needs of the individual patient. Biomarkers may reflect the degree of immunosuppression of the immune system, or they may reflect early damage to the transplanted organ.

Additional Metadata
Keywords Biomarkers, Immunosuppression, Rejection, Transplantation
Persistent URL dx.doi.org/10.1111/bcp.13391, hdl.handle.net/1765/101945
Journal British Journal of Clinical Pharmacology
Citation
van Gelder, T. (2017). Biomarkers in solid organ transplantation. British Journal of Clinical Pharmacology. doi:10.1111/bcp.13391